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Objective: To examine the hypothesis that the „natural“ combination of delusions and 
hallucinations in psychotic disorders in fact represents a selection of early subclinical 
hallucinatory experiences associated with delusional ideation, resulting in need for care and 
mental health service use. Methods: In the Early Developmental Stages of Psychopathology 
study, a prospective, 10-year follow-up of a representative cohort of adolescents and young 
adults in Munich, Germany (n 5 2524), clinical psychologists assessed hallucinations and 
delusions at 2 time points (T2 and T3). Analyses compared differences in psychopathology, 
familial liability for nonpsychotic disorder, nongenetic risk factors, persistence, and clinical 
outcome between groups characterized by: (1) absence of positive psychotic symptoms, (2) 
presence of isolated hallucinations, (3) isolated delusions, and (4) both hallucinations and 
delusions. Results: Delusions and hallucinations occurred together much more often (T2: 
3.1%; T3: 2.0%) than predicted by chance (T2: 1.0%; T3: 0.4%; OR 5 11.0; 95% CI: 8.1, 
15.1). Content of delusions was contingent on presence of hallucinations but modality of 
hallucinations was not contingent on presence of delusions. The group with both 
hallucinations and delusions, compared to groups with either delusions or hallucinations in 
isolation, displayed the strongest associations with familial affective liability and nongenetic 
risk factors, as well as with persistence of psychotic symptoms, comorbidity with negative 
symptoms, affective psychopathology, and clinical need. Conclusions: The early stages of 
psychosis may involve hallucinatory experiences that, if complicated by delusional ideation 
under the influence of environmental risks and (liability for) affective dysregulation, give rise 
to a poor prognosis hallucinatory–delusional syndrome.  
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Introduction  
 
The early origins of psychotic illness in the general population remain poorly understood.1 
Informative findings come from a handful of prospective general population studies showing 
that the onset of psychotic disorder can be seen as the outcome of earlier subthreshold 
expressions of psychotic signs and symptoms.2–4 Study results show that the majority of 
persons with subthreshold expression of psychotic symptoms (prevalence: 5%–10%5) never 
convert to psychotic disorder and that in those who do, the number and severity of 
subthreshold psychotic symptoms, and their degree of persistence, under the influence of 
environmental exposures such as childhood trauma, cannabis use and an urban 
environment,6,7 are important predictors.8 Furthermore, not just the presence of psychotic 
symptoms per se, but the psychopathological and developmental context determines the 
longer-term outcome, particularly the degree of admixture with affective dysregulation, 
negative symptoms, and premorbid social dysfunction.9–11  
 
One important hypothesis that has remained difficult to examine empirically regards the 
relationship between perceptual abnormalities and delusional ideation in the early expression 
of psychosis. Whilst delusions and hallucinations in psychotic disorder are seen as symptoms 
that naturally pertain to the same „class“ of positive symptoms, they in fact refer to very 
different phenomena and there is very little research, or empirical evidence, on possible 
reasons and consequences for their co-occurrence. The observed correlation between 
delusions and hallucination has only rarely been the topic of empirical research, in terms of 
going beyond mere correlation to actual investigation of what this correlation may mean, 
comparing, on the one hand, delusions and hallucinations in isolation vs, on the other, their 
co-occurrence in relation to etiological and clinical parameters. In clinical samples this would 
be difficult, given correlations secondary to Berkson’s bias or comorbidity bias,12,13 and the 
fact that antipsychotic treatments successfully suppress (clustering of) positive psychotic 
symptoms. At the general population level, however, comparative empirical research is valid 
and important, as in individuals with subclinical expression of symptoms, the pathway from 
early expression to clinical needs may critically depend on level of „comorbidity“ of 
symptoms, and its clinical consequences, over time.  
 
Many of the theories that have relevance for the observation of co-occurrence of delusions 
and hallucinations14–20 contain elements that, at least in part, are compatible with arguably the 
oldest and best established theory, that delusions may be seen as „complicating“ abnormal 
perceptual processes21–23 or, as described more recently, aberrant attribution of salience.24 This 
theory has some empirical support25–28 and is of major clinical relevance, as it implies that 
clustering of hallucinatory and delusional ideation represents a significant deepening of the 
psychotic state. There is some support for this hypothesis, given evidence that clustering of 
hallucinations and delusional ideation is particularly likely in the presence of affective 
dysregulation,29 a factor which previous work suggests is essential in the early formation and 
clinical outcome of psychotic experiences.9,30–35  
 
The theory that hallucinatory experiences may present with or without delusional ideation is 
particularly relevant from the early psychosis perspective, as it suggests that the co-
occurrence of delusions and hallucinations in psychotic disorder may not be „natural“ but, on 
the contrary, the result of a dynamic selection with prognostic consequences: of the 
individuals in the general population who experience anomalous perceptions, those with 
„comorbid“ delusional ideation may be more likely to develop need for care and thus become 
diagnosable cases when they present to psychiatric services.  
 
The current analysis focused on a general population sample that was followed over time, 
with repeated assessments, administered by clinical psychologists, of the spectrum of 
psychotic symptoms, in combination with assessment of dysfunction and help-seeking. The 
following hypotheses were examined:  
 
1. Hallucinations and delusions cluster together more often than would be expected by 
chance.  
 
2. Co-occurrence of delusions and hallucinations, compared to either one in isolation, is more 
strongly associated with parameters predicting transition to clinical outcome, such as more 
persistence over time, comorbid affective dysregulation, negative symptoms, suicidal 
ideation, anxiety, and familial psychopathology.  
 
3. Although it is difficult to directly examine the hypothesis relating to the more theoretical 
issue that the dynamic sequence over time is from hallucinations to secondary delusional 
ideation, this hypothesis can be examined indirectly by showing that (1) the content of 
delusions differs as a function of whether or not hallucinations are present whereas (2) 
modality of hallucinations does not vary as a function of whether or not delusions are present. 
In other words, confirmation of hypothesis III would yield evidence that delusions „follow“ 
hallucinations but not the other way around.  
 
4. Co-occurrence of delusions and hallucinations, compared with either one in isolation, is 
more strongly associated with environmental exposures, such as childhood trauma, cannabis 
use, and an urban environment.  
 
Methods  
 
Sample  
 
Data were from the Early Developmental Stages of Psychopathology (EDSP) Study, which 
collected data on the prevalence, incidence, risk factors, comorbidity, and course of mental 
disorders in a random, representative population sample of adolescents and young adults in 
the general population. The baseline sample was randomly drawn, in 1994, from the 
respective population registry offices of Munich and its 29 counties to mirror the distribution 
of individuals expected to be 14–24 years of age at the time of the baseline (T0) interview in 
1995. More details on the sampling, representativeness, instruments, procedures, and 
statistical methods of the EDSP Study sample have previously been presented.36,37 The EDSP 
study was approved by the Ethics Committee of the Technical University Dresden.  
 
Study Design  
 
The design of EDSP is longitudinal and prospective, consisting of a baseline (T0) and 3 
follow-up surveys, covering a time period of on average 1.6 years (T0–T1, SD = 0.2), 3.5 
years (T0–T2, SD = 0.3), and 8.4 years (T0–T3, range = 7.3–10.5 years, SD = 0.7). Because 
the primary goal was to examine the incidence and developmental risk factors for 
psychopathology, the younger group (14–15 years), presumed to have the highest incidence 
density, was sampled at twice the rate of persons aged 16–21 years, and the oldest group (22–
24 years) was sampled at half this rate. For the same reason, subjects aged 14–17 years at 
baseline were examined at the 4 time points, and subjects aged 18–24 years were assessed 
only 3 times. Written informed consent was obtained from all subjects.  
 
The G-section of the DIA-X/M-CIDI, which focuses on psychosis, was administered at T2 
(lifetime version section G) and T3 (interval version T2–T3 of section G). For the current 
article and analyses, the T2 sample served as baseline because psychotic symptoms were first 
assessed at T2. The baseline sample consisted of 3021 individuals aged 14–24 years; at T2, 
2548 participants were reinterviewed (response rate = 84%) and 2210 (73%) at T3.  
 
Instruments  
 
The Self-report Symptom Checklist-90R. At all time points, participants completed the 
previously validated self-report symptom checklist-90R (SCL-90R), the time frame of which 
is the past 2 weeks, oriented to screen for a broad range of psychological problems and 
psychopathology. 38 It contains 90 items, scored on a 5-point severity scale, measuring 9 
primary symptom dimensions named „somatization,“ „obsessive-compulsive,“ „interpersonal 
sensitivity,“ „depression,“ „anxiety,“ „hostility,“ „phobic anxiety,“ „paranoid ideation,“ and 
„psychoticism.“  
 
The Munich-Composite International Diagnostic Interview. Participants were assessed 
using the computerized version of the Munich-Composite International Diagnostic Interview 
(DIA-X/M-CIDI),39,40 an updated version of the World Health Organization’s CIDI version 
1.2.41 The DIA-X/M-CIDI is a comprehensive, fully standardized diagnostic interview and 
assesses symptoms, syndromes, and diagnoses of various mental disorders in accordance with 
the definitions and criteria of the International Classification of Diseases, Tenth Revision 
(ICD-10) and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-
IV), along with information about onset, duration, severity of symptoms, and psychosocial 
impairment as well as interviewer observations.  
 
As the assessment of psychosis with the CIDI by lay interviewers is not considered 
reliable,40,42 trained clinical interviewers at the level of clinical psychologist, who were 
allowed to probe with follow-up clinical questions, conducted the interviews in the 
respondents’ homes.  
 
At baseline, the DIA-X/M-CIDI lifetime version was used. At each of the follow-up 
assessments, interviewers administered the interval version, covering the period from the last 
interview until the next.  
 
Psychopathology. „Hallucinations and delusions“ were assessed at T2 and T3 with the G-
section of the DIA-X/ M-CIDI. G-section delusions were: being spied on (G1), being 
followed (G2), being tested (G3), conspiracy (G4), being loved by a stranger (G5), can read 
thoughts (G7), can hear thoughts of other people (G8), thoughts being heard by others (G9), 
controlled by force (G10), being given thoughts (G11), thoughts being taken (G12), messages 
specially directed at the person (G13), song or book directed specially at the person (G13b), 
influenced by strange force (G14), and forced to move (G22a). G-section hallucinations were: 
seeing things which others could not see (G17), hearing things which others could not hear, 
like voices or noises (G18), smelling things which others did not smell (G20), having a 
strange taste in the mouth without reasonable explanation (G20c), and feeling things or 
sensations on one’s body without external stimulus (G21a). Each variable was coded 1 if the 
item was present and 0 if the item was absent. At both T2 and T3, a variable (hereafter: 
group) denoting the different combinations between delusions and hallucinations was 
constructed as follows: „no psychotic symptoms“ (value „0“; all delusions = 0 and all 
hallucinations = 0), „isolated delusions“ (value „1“; any delusion = 1 and all hallucinations = 
0), „isolated hallucinations“ (value „2“; all delusions = 0 and any hallucination = 1), 
hallucinations and delusions (value „3“; any delusion = 1 and any hallucination = 1).  
 
At T2 and T3, 2 items concerning negative and disorganized symptoms from the DIA-X/M-
CIDI interview ratings X-section were used: (1) indifference (X11) and (2) thought 
incoherence and/or illogicality (X12). In addition, at T2, not only items X11 and X12 were 
assessed but also 5 items of the DIA-X/M-CIDI interview observational P-section were 
available: flat affect (item P03), slow speech (item P05), reduced movement (item P06), 
reduced speech (item P07), and lack of goal-directed behavior (item P08). All items were 
rated dichotomously as absent or present. Conform previous analyses in this sample,43 a 
dichotomous variable „negative symptoms“ was created, a value of 0 indicating ratings of 
absent on all 7 items of the X- and P-sections at T2 and the 2 X11 and X12 items at T3, a 
value 1 indicating a rating of present on any of the 7 items at T2 and any of the 2 items at T3. 
T2 and T3 measures of negative symptoms were described and validated in a previous 
publication.10  
 
Depressive and Manic Symptoms. Depressive and manic symptoms were assessed at T2 and 
T3 using the 28 symptom items of the DIA-X/M-CIDI depression and dysthymia section and 
the 11 symptom items of the DIAX/M-CIDI mania section that follow the DSM-IV and ICD-
10 criteria. As described previously,9 a continuous „(hypo)mania score“ was constructed 
consisting of the sum score of manic symptoms with a theoretical range of 0–11 symptoms, 
recategorized to 4 categories of increasing numbers of manic symptoms. Similarly, a 
continuous sum score of depression symptoms was constructed with a theoretical range of 0–
28 symptoms (hereafter: „depression score“), recategorized to 6 categories of increasing 
numbers of depressive symptoms.9   
 
Substance Abuse or Dependence. T2 and T3 alcohol dependence or abuse was assessed 
dichotomously (absence = 0, presence = 1) using section I of the DIA-X/ M-CIDI, which 
follows the criteria from the DSM-IV. Similarly, at T2 and T3, a dichotomous composite 
variable indicating any use of cannabis, amphetamine, cocaine, ecstasy, angel dust, opiates, 
glue, or other drug of abuse in excess of more than 5 times (for each drug separately) was 
constructed, based on questions regarding drug use from the DIA-X/M-CIDI L-section at T2 
and T3, respectively. The rationale for using a cutoff point of „more than 5 times drug use“ is 
described in more detail elsewhere.44  
 
Anxiety. The variable „any anxiety disorder“ was derived from the DIA-X/M-CIDI D-
section, which explores the presence of Panic Disorder with or without agoraphobia, 
Agoraphobia without a history of panic disorder, Social phobia, Specific phobia, Anxiety 
disorder NOS, Generalized anxiety disorder, and Obsessive– compulsive disorder. A T2 and 
T3 dichotomous variable „any anxiety disorder“ was constructed indicating the presence of 
any anxiety disorder at these time points.  
 
Assessment of Persistence of Psychotic and Negative symptoms. Conform previous 
research in this sample, the SCL-90R psychoticism and paranoid ideation subscales were 
combined into one Psychosis scale (hereafter „SCL-psychosis scale“) by summing their 
scores.44 The correlation between this SCL-psychosis scale and the variable expressing the 
number of M-CIDI psychotic symptoms at T3 (when the interval assessment of the M-CIDI 
was closest to the time window of 2 weeks of the SCL-90R) was 0.33. For the SCL-90R 
anxiety scale, the correlation was -0.01, suggesting convergent and discriminant validity of 
the SCL-psychosis scale. As described previously,8 a discrete variable for longitudinal 
persistence of psychotic symptoms was constructed for each participant on the basis of the T0, 
T2, and T3 measures of the SCL-psychosis subscale by (1) dichotomizing the SCL-psychosis 
scales around the 90% percentile at each time point and (2) making a score of the number of 
times individuals had scores in the highest 10% at T0, T2, and T3. Thus, a variable for the 10-
year persistence of psychotic symptoms across T0, T2, and T3 was rated 0 (never), 1 (once), 
or 2 (twice) or 3 (thrice), hereafter „10-year psychosis persistence,“ which was assessed 
independently of the measures of T2 and T3 psychotic symptoms described above.  
 
Persistence of Negative Symptoms. Similarly, as described in more detail previously,43 a 
variable indicating the 10-year persistence of negative symptoms was constructed based on 
presence of any negative symptom rated at T0 (assessed in the same fashion as at T3 using the 
X11 and X12 items, see above), T2 and T3, rated 0 (never), 1 (once), or 2 (twice) or 3 
(thrice), hereafter „10-year negative symptom persistence.“  
 
Assessment of Clinical Relevance of Positive Psychotic Symptoms. Help-seeking. As 
described previously,8 help-seeking secondary to psychotic symptoms at T2 and T3 was 
assessed using 3 DIA-X/M-CIDI items. Two psychosis section items were used: G16 
(delusions) and G23 (hallucinations), which were phrased as follows: „Did you tell a doctor 
about . (the psychosis-section hallucinatory/delusional item previously endorsed by the 
participant along with a visual representation from the response booklet) you have had?“ A 
third item from the concluding section was added (Q1DG); participants were shown a list of 
several types of outpatient or inpatient institutions for mental health problems and asked 
whether they had ever sought help at any of those institutions because of psychotic symptoms 
from the DIA-X/M-CIDI G section. Using these 3 help-seeking behavior items, a 
dichotomous variable „help-seeking“ was constructed, indicating a positive answer on any of 
the 3 questions (1) vs negative answers on all 3 questions (0).  
 
Dysfunction. As described previously,8 dysfunction due to psychotic symptoms was assessed 
using the following DIA-X/M-CIDI G-section items: (G28) feeling upset, unable to work, go 
places, enjoy oneself at the time of these experiences; (G29) being less able to work since the 
onset of the experiences; (G29a) being less able to make friends or enjoy social relationship 
since the onset of these experiences; (G36) how much daily life and everyday activities were 
impaired when the experiences were at their worst. The dichotomous variable „dysfunction“ 
was rated 1 for any positive endorsement and 0 for a negative rating on all 4 items.  
 
Thinking about Death. Conform previous work in this sample,46 the dichotomous variable 
„thinking about death“ was used as a measure for suicidal ideation. This was assessed at T2 
and T3 with the question „Did you think a lot about death in general, your own death or that 
of other persons?“ (DIA-X/M-CIDI item E37).  
 
Caseness. The X16 DIA-X/M-CIDI item (assessed at T2–T3) was used to assess „caseness.“ 
This item rates the interviewer’s opinion regarding clinical evidence of psychological ill 
health and consists of 4 levels: essentially not noticeable (0), not very noticeable (1), clearly 
ill (2), and very ill (3). The dichotomous variable „caseness“ was defined as any score above 
1.  
 
Nongenetic Risk Factors. The variable „trauma at T0“ was constructed with the N1-list from 
the DIA-X/MCIDI, as described previously.46 Trauma at T0 was coded 0 (absence of trauma 
at T0) or 1 (endorsement on any trauma item at T0). Cannabis use was measured with list L1 
of the DIA-X/M-CIDI L-section in which participants had to indicate which substances they 
used and how often. A dichotomous variable „use of cannabis for 5 times or more at T0“ was 
created and rated as „yes“ (value label: 1) or „no“ (value label: 0). The last environmental risk 
factor was „urbanicity T0“ (based on information of the German registration office: living in 
Munich = 1/living rural = 0; the population density of the Munich area is 4601 persons per 
square mile, that of surrounding areas is 553 persons per square mile).  
 
Assessment of Family History. Given strong associations between psychotic disorder and 
nonpsychotic disorder in relatives,47 nonpsychotic parental mental illness variables were 
calculated on the basis of M-CIDI interviews with the parents at T1 that were only available 
for the youngest group aged 14–17 years at baseline. Family history variables thus were only 
created for the younger group. The following disorders, rated absent or present, were derived 
from the M-CIDI interview: „parental substance abuse and dependence,“ „parental alcohol 
abuse and dependence,“ „parental substance and alcohol misuse.“ „parental manic symptoms“ 
and „parental depressive symptoms“ were assessed at T1 via, respectively, the F-section and 
the E-section of the M-CIDI. The total number of endorsed items was recoded into a 
continuous sum score as described above for the variables „depressive score“ and 
„(hypo)mania score.“  
 
Analysis  
 
All analyses were carried out using STATA version 11.0.48 Given the fact that cumulative 
incidence rates of psychotic symptoms were measured twice, (lifetime at T2 and interval T2–
T3 at T3), data were analyzed in the „long format,“ each individual contributing 2 
observations (T2 and T3) for analysis, conform previous work.43 In order to correct for the 
clustering of multiple observations within subjects, cluster–robust SEs were computed, using 
the CLUSTER option in the MLOGIT module in STATA. All analyses were additionally 
adjusted for age and sex.  
 
It was tested whether the type of delusion discriminated between individuals with only 
delusions and individuals with both delusions and hallucinations (ie, are delusions contingent 
on hallucinations) and, conversely, whether the type of hallucination discriminated between 
individuals with only hallucinations and individuals with both delusions and hallucinations 
(ie, are hallucinations contingent on delusions).  
 
Multinomial logistic regression of the variable „group“ was carried out, estimating 
associations, expressed as ORs and 95% CI in relation to the following groups of independent 
variables: (1) outcome: helpseeking, dysfunction, suicidal ideation, caseness, and persistence 
of positive and negative symptoms; (2) comorbid psychopathology: negative symptoms, 
depressive symptoms, manic symptoms, any anxiety disorder, any drug use, alcohol 
abuse/dependence; (3) parental history of nonpsychotic illness: alcohol/substance misuse, 
depressive symptoms, manic symptoms; and (4) risk factors: trauma, cannabis use, and 
urbanicity. ORs were compared by Wald test.  
 
Risk Set. Information on the G-section of the DIA-X/ M-CIDI was available for 2524 
participants at T2 (lifetime version) and for 2210 at T3 (interval T2–T3 version). In the long 
format, the risk set consisted of 4734 observations, except for the analyses on family history 
(1787 observations, youngest subgroup only) and the analysis on negative symptoms (4063 
observations) due to missing data on the 10-year negative symptom persistence variable.  
 
Results  
 
Subject Characteristics  
 
The sample distribution of demographic variables for T2 and T3 is displayed in table 1.   
 
Pattern of Co-occurrence Hallucinations and Delusions  
 
Delusions and hallucinations occurred together much more often (T2: 3.1%; T3: 2.0%) than 
predicted by chance (T2: 1.0%; T3: 0.4%) (table 2). The OR for association was 11.0 (95% 
CI: 8.1, 15.1). In addition, delusional content differed as a function of the copresence of 
hallucinations (table 3): G-section items most likely to distinguish individuals with only 
delusions from individuals with both hallucinations and delusions were thoughts being heard 
by others (OR = 4.0, 95% CI: 2.1, 7.3), thoughts being taken (OR = 8.7, 95% CI: 2.3, 33.6), 
and messages directed at the person (OR = 6.3, 95% CI: 2.9, 14.0). Conversely, however, type 
of hallucination did not differ as a function of presence of delusions (table 4).  
 
Clinical Relevance, Comorbidity, and Persistence  
 
The pattern of results was that all groups (hallucination and delusions, hallucinations only, 
delusions only) differed from the reference group without psychotic symptoms on all 
variables. However, the group with both hallucinations and delusions, compared with the 
other 3 groups, displayed stronger associations for each variable reflecting clinical relevance 
(table 5). The highest risk was for the variable help-seeking: 35.5% of individuals with 
delusions and hallucinations had sought help, compared with 7.7% in the group with only 
hallucinations, 8.7% in the group with only delusions, and 0.1% in the reference group.  
 
Similarly, individuals with both delusions and hallucinations consistently had the highest rates 
of comorbidity, although not always at conventional statistical level (table 6). The greatest 
observed difference was for anxiety disorder: the rate was 45.5% in those with delusions and 
hallucinations, compared to 26.2% and 21.7% in those with, respectively, only hallucinations 
and only delusions and 14.2%in the reference group. Similarly, rates of negative symptoms 
were, respectively, 21.5%, 15.4%, 16.0%, and 11.7%.  
 
Nearly 25% in the group with delusions and hallucinations had persistence of positive 
psychotic experiences over 2 or 3 measurements, significantly higher than all other groups 
(delusions only: 10.5%, hallucinations only: 13.9%, reference group: 3.0%; table 7). A 
directionally similar but much more attenuated pattern was apparent for persistence of 
negative symptoms (table 8).  
 
Family History and Nongenetic Risk Factors  
 
The group with delusions and hallucinations consistently had the highest level of parental 
psychopathology, although differences between groups were mostly not statistically 
significant (table 9).  
 
A similar pattern, with more contrast between the groups, was apparent for the nongenetic 
risk factors, with the clearest result for childhood trauma. The rate of trauma exposure for 
individuals with delusions and hallucinations was 34.7%, significantly higher than the rates 
observed in individuals with delusions only (23.8%), hallucinations only (13.9%), and the 
reference group (18.3%). A similar pattern was observed for the other exposures (table 10).  
 
Discussion  
 
Main Findings  
 
Co-occurrence of Delusions and Hallucinations. At the level of the general population, the 
combination of delusional ideation and hallucinatory experiences co-occurred more often than 
would be expected by chance, which points to the direction of a fundamental unifying 
mechanism, independent of illness, hereafter referred to as „hallucinatory–delusional 
syndrome.“ Furthermore, the pattern of results in tables 3 and 4 indicates that delusional 
content is contingent on the presence of hallucinations, whereas type of hallucination is not 
contingent on presence of delusions, suggesting delusions may represent a cognitive response 
to hallucinations and a deepening of the psychotic state, in agreement with earlier theories 
formulated by Maher and Ross and, more recently, Kapur.21–24 These findings, combined with 
the fact that the group with only hallucinations tended to show the weakest difference with the 
nonpsychotic group, support the notion that a specific subgroup of the population is at risk of 
worsening of psychosis through secondary delusion formation, given hallucinatory 
experiences, and that delusion formation may be associated with affective predisposition and 
nongenetic risk factors.  
 
Delusions, Hallucinations, and Other Perceptual Anomalies. A number of issues need 
explaining. First, the rate of hallucinations was much lower than delusions. An unlikely 
explanation is that most delusions represent false positives and most hallucinations true 
positives, given the fact that the clinical relevance of isolated delusions was greater than 
isolated hallucinations. A more likely (partial) explanation is that the M-CIDI measures for 
delusions are more sensitive and numerous than those for hallucinations and, additionally, that 
a range of more subtle, „basic“49,50 perceptual anomalies can occur in the early phases of 
psychosis that are not picked up by the M-CIDI. This would also explain why, on most 
measures, isolated delusions impacted more on measures of clinical severity than isolated 
hallucinations.  
 
Second, the fact that certain, mostly „first-rank-type“ delusions were more specifically 
associated with hallucinations than others suggests that delusions „follow“ hallucinations but 
also that the content of secondary delusional ideation is not random, and often takes on the 
form of altered self-representation and social inference, resulting in experience of thought 
alienation, passivity-like experiences and paranoia. To the degree that hallucinations are at the 
severest end of perceptual anomalies associated with psychosis, it may be hypothesized that 
other types of delusions, that in this study were less „comorbid“ with hallucinatory 
experiences, represent cognitive schemes associated with less severe perceptual anomalies 
that are not picked up by the M-CIDI.  
 
The Hallucinatory–Delusional Syndrome as a Predictor of Clinical Outcomes. 
Furthermore, the results showed that the combination of hallucinations and delusions, 
compared with either one in isolation, may represent an important intermediate step toward 
transition to (1) persistence of symptoms and (2) clinical outcomes, which may be mediated, 
to a degree, by negative symptoms43 and by higher rates of comorbid nonpsychotic 
psychopathology or familial liability to nonpsychotic psychopathology, particularly parental 
mania, conform earlier observations.33,35,51,52  
 
The Hallucinatory–Delusional Syndrome as an Outcome of Nongenetic Risk Factors. 
The results suggest that environmental risk factors for psychotic illness may act in part by 
increasing the risk of delusional ideation in individuals experiencing perceptual alterations. 
This would go some way toward explaining why associations between childhood trauma and 
either hallucinations or delusions have been inconsistent.53  
 
A Two-Stage Hallucinatory–Delusional Syndrome Underlying Psychotic Illness  
 
The findings suggest that the early stages of psychosis may involve perceptual anomalies 
perceived as hallucinations that, if complicated by delusional ideation under the influence of 
environmental risks and (liability for) affective dysregulation, give rise to a hallucinatory–
delusional syndrome that is associated with a higher probability of persistence of psychotic 
symptoms and transition to clinical psychotic disorder. Thus, identifying the group of patients 
with first-stage early perceptual alterations may lead to expanded insight and knowledge 
about the premorbid stages of psychosis, particularly if more is known about second-stage 
onset of delusional ideation. Few studies have focused on the onset of delusional formation 
following hallucinatory experiences. Two studies reported that in those with hallucinations, 
voice characteristics and the level of distress28 they generate, in a context of affective 
dysregulation and negative schemata associated with childhood trauma, may increase the risk 
for secondary delusion formation.27 Another study found that in the general population, 
trauma impacts on delusion formation through an affective pathway.54  
 
Limitations and Methodological Issues  
 
The data presented in the current article were gathered in a large epidemiological study; 
therefore, instruments and tools used were not refined with regard to the hypotheses under 
investigation. Second, follow-ups were infrequent, precluding the investigation of the 
dynamic relationship between delusions and hallucinations over time. Therefore, although the 
data suggest that hallucinations may be followed by delusional ideation, an alternative 
explanation is that delusions are a cross-sectional indicator of the severity of the underlying 
process that also affects perceptual alterations. While this would also be an important 
observation, it differs substantially from the more dynamic interpretation given above. 
Therefore, more fine-grained follow-up work is necessary. Third, no formal diagnoses were 
used for psychotic disorder. The reason for this is that in general population samples, 
diagnoses are less sensitive than multiple indicators of help-seeking, dysfunction, and 
caseness, that better reflect the dimensional nature of the largely subsyndromal expression of 
psychosis. Fourth, the measure of psychosis persistence was based on SCL-90R self-report 
measures. Although analyses against the interview-based M-CIDI measures of psychotic 
symptoms suggested convergent and discriminant validity, self-report may have generated 
false positive psychotic experiences, increasing random error. Nevertheless, a substantial 
amount of literature exists on the validity of self-reported psychotic symptoms, SCL-90R and 
other instruments, suggesting acceptable validity and reliability.5,55–57  
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